SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-134779
Filing Date
2018-04-26
Accepted
2018-04-26 16:11:56
Documents
5
Period of Report
2018-06-06
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d568389ddef14a.htm DEF 14A 308140
2 GRAPHIC g568389g0503022813597.jpg GRAPHIC 3274
3 GRAPHIC g568389g27w13.jpg GRAPHIC 2003
4 GRAPHIC g568389g35g96.jpg GRAPHIC 31248
5 GRAPHIC g568389g37x96.jpg GRAPHIC 8800
  Complete submission text file 0001193125-18-134779.txt   366811
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 18778653
SIC: 2834 Pharmaceutical Preparations